Methodologies for the Formation of 2-Substituted Oxetanes: Synthesis of (<i>S</i>)-Oxetan-2-ylmethyl Tosylate
The compound (S)-oxetan-2-ylmethyl tosylate 1 was identified as a key synthetic fragment for the introduction of the 2-substituted oxetane functionality in potential drug candidates under development in our laboratories. The focus of this paper is to highlight methodologies evaluated in our quest for synthetic routes to 2-substituted oxetanes suitable for enabling manufacture. Of the five routes investigated, three (Route 1A, Route 2, and Route 3) were successfully demonstrated in the laboratory. Subsequently, Route 3 was executed at scale to deliver metric ton quantities of the oxetane tosylate 1 as a solution in EtOAc, which was integrated into the synthesis of 2 and aforementioned drug candidates.
Authors
- Emily K. Rose
- Philip Peach
- Nessa Carson (ORCID: https://orcid.org/0000-0002-2769-1775)
- Matthew Badland
- Maria S. Brown (ORCID: https://orcid.org/0000-0001-5534-4327)
- Adam Scott
- Douglas J. Critcher
- Heather Ingram
- Michael Hawksworth
- Steven J. Fussell
- Steven J. R. Twiddle (ORCID: https://orcid.org/0009-0000-2670-0070)
- Jinu S. Mathew
- Rebecca Johnson (ORCID: https://orcid.org/0000-0003-2475-6622)
- Laura McGivern
- Rajesh Kumar (ORCID: https://orcid.org/0000-0002-7504-5620)
- Ben Pibworth
- Alexandru I. Pop
- Nathan J. Rutland
Institutions
- University of Wolverhampton (GB)
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
Publication Details
- Journal
- Organic Process Research & Development
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1021/acs.oprd.4c00514
- Citations
- 2
- Primary Topic
- Chemical Reactions and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 3.51